National Cancer Diagnosis Audits for England 2018 versus 2014: a comparative analysis
British Journal of General Practice · 2023
DOI: 10.3399/bjgp.2022.0268 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of General Practice, 2023. Verfasst von Ruth Swann und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research UK, London. Hauptthemen laut MEDLINE: Neoplasms, General Practice. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK.
Abstract (Originalsprache)
Background
Timely diagnosis of cancer in patients who present with symptoms in primary care is a quality-improvement priority.
Aim
To examine possible changes to aspects of the diagnostic process, and its timeliness, before and after publication of the National Institute for Health and Care Excellence's (2015) guidance on the referral of suspected cancer in primary care. Design and setting Comparison of findings from population-based clinical audits of cancer diagnosis in general practices in England for patients diagnosed in 2018 or 2014.
Method
GPs in 1878 (2018) and 439 (2014) practices collected primary care information on the diagnostic pathway of cancer patients. Key measures including patient characteristics, place of presentation, number of pre-referral consultations, use of primary care investigations, and referral type were compared between the two audits by descriptive analysis and regression models.
Results
Among 64 489 (2018) and 17 042 (2014) records of a new cancer diagnosis, the percentage of patients with same-day referral (denoted by a primary care interval of 0 days) was higher in 2018 (42.7% versus 37.7%) than in 2014, with similar improvements in median diagnostic interval (36 days versus 40 days). Compared with 2014, in 2018: fewer patients had ≥3 pre-referral consultations (18.8% versus 26.2%); use of primary care investigations increased (47.9% versus 45.4%); urgent cancer referrals increased (54.8% versus 51.8%); emergency referrals decreased (13.4% versus 16.5%); and recorded use of safety netting decreased (40.0% versus 44.4%).
Conclusion
In the 5-year period, including the year when national guidelines were updated (that is, 2015), there were substantial improvements to the diagnostic process of patients who present to general practice in England with symptoms of a subsequently diagnosed cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Research UK, London.
- National Cancer Registration and Analysis Service, NHS Digital, Leeds.
- University of Exeter Medical School (Primary Care), University of Exeter, Exeter.
- Cystic Fibrosis Trust, London; former NCDA programme manager, Cancer Research UK, London.
- NHS Implementation & External Affairs; former director, Cancer Intelligence, Early Diagnosis and Clinical Engagement, Cancer Research UK, London.
- University College London, London.
ORCID-Profile: Ruth Swann, Gary A Abel, Lorna Wills, Georgios Lyratzopoulos, Greg Rubin
Förderung
- Cancer Research UK
Zitieren
APA
Swann, R., McPhail, S., Abel, G. A., Witt, J., Wills, L., Hiom, S., Lyratzopoulos, G., & Rubin, G. (2023). National Cancer Diagnosis Audits for England 2018 versus 2014: a comparative analysis. British Journal of General Practice. https://doi.org/10.3399/bjgp.2022.0268
Vancouver
Swann R, McPhail S, Abel GA, Witt J, Wills L, Hiom S, et al. National Cancer Diagnosis Audits for England 2018 versus 2014: a comparative analysis. British Journal of General Practice. 2023. doi:10.3399/bjgp.2022.0268
BibTeX
@article{Swann2023,
author = {Swann, Ruth and McPhail, Sean and Abel, Gary A and Witt, Jana and Wills, Lorna and Hiom, Sara and Lyratzopoulos, Georgios and Rubin, Greg},
title = {National Cancer Diagnosis Audits for England 2018 versus 2014: a comparative analysis},
journal = {British Journal of General Practice},
year = {2023},
doi = {10.3399/bjgp.2022.0268}
}
EUVIMED